SonoScape Medical Corp (300633) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.042x

Based on the latest financial reports, SonoScape Medical Corp (300633) has a cash flow conversion efficiency ratio of -0.042x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-130.62 Million ≈ $-19.11 Million USD) by net assets (CN¥3.12 Billion ≈ $456.43 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can SonoScape Medical Corp fund operations to measure how many days the company can operate on defensive assets alone.

SonoScape Medical Corp - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how SonoScape Medical Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SonoScape Medical Corp Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SonoScape Medical Corp ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
JiShi Media Co Ltd
SHG:601929
0.025x
Liberty Latin America Ltd Class C
NASDAQ:LILAK
0.041x
COMPUGROUP MED.SP.ADR 1
F:COPA
N/A
Ningbo Menovo Pharm Co Ltd
SHG:603538
0.016x
Lontium Semiconductor Corp. A
SHG:688486
N/A
Anhui Estone Materials Technology Co Ltd
SHG:688733
-0.014x
Parksystems Corp
KQ:140860
0.014x
Red Star Macalline Group Corp Ltd Class A
SHG:601828
0.009x

Annual Cash Flow Conversion Efficiency for SonoScape Medical Corp (2012–2025)

The table below shows the annual cash flow conversion efficiency of SonoScape Medical Corp from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see 300633 market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.26 Billion
≈ $477.40 Million
CN¥-48.16 Million
≈ $-7.05 Million
-0.015x -114.96%
2024-12-31 CN¥3.11 Billion
≈ $454.83 Million
CN¥306.66 Million
≈ $44.87 Million
0.099x -37.15%
2023-12-31 CN¥3.15 Billion
≈ $460.35 Million
CN¥493.88 Million
≈ $72.27 Million
0.157x -9.12%
2022-12-31 CN¥2.74 Billion
≈ $400.92 Million
CN¥473.26 Million
≈ $69.25 Million
0.173x +34.27%
2021-12-31 CN¥2.36 Billion
≈ $344.64 Million
CN¥302.99 Million
≈ $44.34 Million
0.129x -36.18%
2020-12-31 CN¥1.34 Billion
≈ $196.81 Million
CN¥271.13 Million
≈ $39.68 Million
0.202x +48.68%
2019-12-31 CN¥1.40 Billion
≈ $205.49 Million
CN¥190.39 Million
≈ $27.86 Million
0.136x -23.93%
2018-12-31 CN¥1.31 Billion
≈ $191.84 Million
CN¥233.65 Million
≈ $34.19 Million
0.178x +38.62%
2017-12-31 CN¥1.06 Billion
≈ $155.02 Million
CN¥136.21 Million
≈ $19.93 Million
0.129x -32.61%
2016-12-31 CN¥720.11 Million
≈ $105.38 Million
CN¥137.38 Million
≈ $20.10 Million
0.191x +91.91%
2015-12-31 CN¥566.21 Million
≈ $82.85 Million
CN¥56.29 Million
≈ $8.24 Million
0.099x -61.06%
2014-12-31 CN¥444.81 Million
≈ $65.09 Million
CN¥113.55 Million
≈ $16.62 Million
0.255x +3.61%
2013-12-31 CN¥365.08 Million
≈ $53.42 Million
CN¥89.94 Million
≈ $13.16 Million
0.246x +459.62%
2012-12-31 CN¥351.82 Million
≈ $51.48 Million
CN¥15.49 Million
≈ $2.27 Million
0.044x --

About SonoScape Medical Corp

SHE:300633 China Medical Devices
Market Cap
$1.14 Billion
CN¥7.78 Billion CNY
Market Cap Rank
#8375 Global
#2016 in China
Share Price
CN¥17.97
Change (1 day)
-4.01%
52-Week Range
CN¥17.97 - CN¥36.61
All Time High
CN¥60.46
About

SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. It offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image processors, ligh… Read more